Efficacy Study of Prednisone Priming to Treat Asian Chronic Hepatitis B Patients

NAWithdrawnINTERVENTIONAL
0
Timeline

Start Date

April 30, 2008

Primary Completion Date

February 28, 2011

Study Completion Date

February 28, 2011

Conditions
Chronic Hepatitis B
Interventions
DRUG

Prednisone Priming

For randomly selected patients treated with steroids: The patients will receive prednisone 30 mg daily for 3 weeks, 15 mg daily for 1 week, no treatment for 2 weeks, followed by Adefovir dipivoxil (Hepsera) 10 mg daily for a minimum of 52 weeks.

Trial Locations (1)

11219

Maimonides Medical Center, Brooklyn

Sponsors
All Listed Sponsors
lead

Maimonides Medical Center

OTHER

NCT00715715 - Efficacy Study of Prednisone Priming to Treat Asian Chronic Hepatitis B Patients | Biotech Hunter | Biotech Hunter